Bristol-Meyers Squibb: A Takeover Target Again?

Bristol-Meyers's Plavix is World's Third-Best Selling Drug; Potential Suitors - Sanovi-Aventis, P...  More »

Bristol-Meyers's Plavix is World's Third-Best Selling Drug; Potential Suitors - Sanovi-Aventis, Pfizer, AstraZeneca, GlaxoSmithKline; Plavix Court Decision Lowers Uncertainly; UBS Sees Takeout Prospects Up to $37/share; Bristol Meyers Declines to Comment on Takeover Talk  « Less